Cluster Headache, Trigeminal Autonomic Cephalalgias (TACs) and Tension-Type Headache

Neurological Conditions

(908) 379-3979 https://www.premierneurohealth.com/

Cluster Headache, Trigeminal Autonomic Cephalalgias (TACs) and Tension-Type Headache

Headache disorders range from the relatively common and mild to some of the most severe pain conditions known in medicine. This Condition Center integrates two major categories:

Cluster Headache & Trigeminal Autonomic Cephalalgias (TACs)
– Rare, severe, and highly disabling unilateral headache syndromes with autonomic symptoms.
Tension-Type Headache (TTH)
– The most common primary headache disorder, often driven by stress, neck tension, and musculoskeletal factors.

Although distinct in mechanism and presentation, both conditions significantly affect quality of life and require accurate diagnosis, personalized therapy, and lifestyle-based interventions.
This unified resource outlines how to recognize, evaluate, and treat these conditions within a structured, neurology-driven framework.

Questions to Ask Your Doctor

For Cluster Headache & TACs

• Do my symptoms fit cluster headache, paroxysmal hemicrania, SUNCT/SUNA, or another TAC?
• Do I need MRI imaging to rule out secondary causes such as pituitary or cavernous sinus lesions?
• Should I try high-flow oxygen or rapid-acting medications like sumatriptan?
• Which preventive options are best for me—verapamil, lithium, CGRP inhibitors, melatonin?
• Would an indomethacin trial clarify my diagnosis?
• Am I a candidate for nerve blocks or neuromodulation?

For Tension-Type Headache

• Are my headaches related to posture, stress, or muscle tension?
• Should I start preventive therapy or rely on non-medication approaches?
• Would physical therapy or TMJ evaluation help reduce symptoms?
• How do I prevent medication-overuse headaches?
• Are sleep or ergonomic issues contributing?

Overview

Cluster headache and TACs represent severe neurovascular disorders involving hypothalamic dysfunction, trigeminal activation, and parasympathetic autonomic pathways. They are among the most painful conditions in neurology.
Tension-type headache, in contrast, reflects musculoskeletal tension, central pain processing, and biopsychosocial stress, and is vastly more common.
These two headache categories are considered together because:

• They frequently coexist with migraine and other primary headache disorders
• They require exclusion of secondary causes
• They respond to structured care pathways
• They benefit from lifestyle, ergonomic, and neuromodulatory interventions
• Patients often struggle to differentiate them without clinical guidance

Together, these disorders form a major portion of headache-related disability in neurology.

What Are Cluster Headache & TACs?

TACs include:

• Cluster headache
• Paroxysmal hemicrania
• Hemicrania continua
• SUNCT/SUNA syndromes

All share:

• Severe unilateral head pain
• Ipsilateral autonomic symptoms (tearing, nasal congestion, facial sweating, eye redness)
• Agitation or restlessness during attacks
• Circadian or seasonal patterns (particularly cluster headache)

Cluster Headache

Characterized by:

• Explosive, severe orbital/temporal pain
• Attacks lasting 15–180 minutes
• Occurring in “clusters” for weeks or months
• Often triggered by alcohol during active cycles
• Nighttime attacks linked to hypothalamic rhythms

Paroxysmal Hemicrania / Hemicrania Continua

Defined by complete responsiveness to indomethacin, making this medication essential for diagnosis.

SUNCT/SUNA

Short-lasting attacks (seconds) with dramatic redness and tearing.

What Is Tension-Type Headache (TTH)?

TTH involves:

• Bilateral pressure or “band-like” tightness
• Pericranial muscle tenderness
• Stress-related exacerbation
• Rare or minimal nausea and sensory hypersensitivity
• No autonomic symptoms

TTH is categorized as:

• Episodic (infrequent or frequent)
• Chronic TTH (≥15 days/month)

Many individuals have mixed migraine + TTH patterns.

What Makes These Conditions More Likely?

Cluster/TACs

• Male sex (particularly cluster headache)
• Smoking history
• Circadian rhythm disruption
• Family history
• Hypothalamic abnormalities

Tension-Type Headache

• Stress, anxiety, sleep disruption
• Prolonged computer/desk work
• Neck and shoulder strain
• TMJ dysfunction or bruxism
• Dehydration
• Eye strain
• Posture imbalance

Signs and Symptoms

Cluster Headache & TACs

• Severe unilateral orbital/temporal pain
• Tearing, eye redness
• Nasal congestion or runny nose
• Eyelid droop or swelling
• Facial sweating
• Restlessness or pacing
• Stereotyped attacks at the same time each day

Paroxysmal Hemicrania

• Short attacks (2–30 minutes)
• ≥5 attacks/day
• Rapid, complete response to indomethacin

Hemicrania Continua

• Continuous unilateral headache with periods of severe exacerbation
• Indomethacin-responsive

SUNCT/SUNA

• Very brief attacks (seconds)
• Prominent autonomic symptoms

Tension-Type Headache

• Bilateral pressure or squeezing sensation
• Tightness in forehead, temples, or neck
• Mild–moderate intensity
• No nausea or vomiting
• Worsens with stress, prolonged sitting, or poor posture
• Improves with rest or relaxation

Exams and Tests

1. MRI Brain with and without Contrast

Essential in TACs to exclude:

• Pituitary adenoma
• Cavernous sinus lesions
• Posterior fossa abnormalities

MRI is optional in classic TTH but recommended if atypical features exist.

2. Indomethacin Test

Diagnostic for:

• Paroxysmal hemicrania
• Hemicrania continua

3. Musculoskeletal / Cervical Evaluation

Important for TTH:

• Neck mobility
• Scapular and paraspinal tension
• Posture analysis
• Ergonomic risk factors

4. TMJ and Dental Assessment

Bruxism and jaw clenching often drive chronic TTH.

5. Sleep Evaluation

Circadian disturbance contributes to cluster cycles and chronic TTH.

Treatment

A. Treating Cluster Headache & TACs

Acute Treatment

• High-flow oxygen (12–15 L/min) — most effective non-pharmacologic therapy
• Subcutaneous sumatriptan
• Intranasal zolmitriptan
• Short steroid taper to break cluster cycles

For SUNCT/SUNA:
• IV lidocaine for rapid control

For hemicrania syndromes:
• Indomethacin is both diagnostic and therapeutic

Preventive Treatment

Cluster headache:

• Verapamil — gold standard
• Galcanezumab (CGRP mAb) — approved for episodic cluster
• Lithium
• Topiramate
• Melatonin
• Occipital nerve block

SUNCT/SUNA:
• Lamotrigine
• Topiramate
• Gabapentin (selected cases)

Neuromodulation

For refractory conditions:

• SPG stimulation
• Occipital nerve stimulation
• Deep brain stimulation (rare, severe cases)

B. Treating Tension-Type Headache

Acute Treatment

• NSAIDs (ibuprofen, naproxen)
• Acetaminophen
• Acetaminophen + caffeine combinations
• Avoid daily use to prevent rebound headache

Preventive Treatment

For frequent or chronic TTH:

• Amitriptyline
• Nortriptyline
• SNRIs (venlafaxine, duloxetine)
• Cognitive-behavioral therapy
• Physical therapy targeted to cervical and trapezius musculature

Physical & Manual Therapy

• Myofascial release
• Trigger-point therapy
• Posture correction
• Ergonomic assessment
• Strengthening and stretching program
• Breathing mechanics and stress reduction

Lifestyle Optimization

• Hydration
• Regular meals
• Sleep stabilization
• Limiting alcohol/caffeine
• Stress reduction practices
• Exercise (aerobic + strength)

Living With TACs or TTH

Most individuals experience meaningful improvement with structured care.

For Cluster/TACs

• Rapid relief with oxygen or injectable triptans
• Significant long-term improvement with preventive therapy
• Seasonal cluster cycles can be anticipated and pre-treated

For Tension-Type Headache

• Physical therapy, stress reduction, posture correction are highly effective
• Preventive medications reduce chronic frequency
• Ergonomics and lifestyle changes provide durable benefit

Did You Know?

• Cluster headache is one of the most severe pains known in neurology—but treatments are highly effective.
• Alcohol reliably provokes cluster attacks only during active cycles.
• Tension-type headache is the most common headache in the world.
• Many patients have “mixed headaches,” requiring treatment strategies for both TACs and TTH.
• Indomethacin responsiveness is pathognomonic for two TAC disorders.

References

Petersen AS, Lund N, Goadsby PJ, et al. Recent Advances in Diagnosing, Managing, and Understanding the Pathophysiology of Cluster Headache. Lancet Neurol. 2024;23(7):712-724.[1]

https://pubmed.ncbi.nlm.nih.gov/38876749

Comprehensive 2024 review of cluster headache pathophysiology, genetics, acute treatments (oxygen 12 L/min, sumatriptan 6 mg subcutaneous), and preventive therapies

Diener HC, Tassorelli C, Dodick DW. Management of Trigeminal Autonomic Cephalalgias Including Chronic Cluster: A Review. JAMA Neurol. 2023;80(3):308-319.[2]

https://jamanetwork.com/journals/jamaneurology/fullarticle/10.1001/jamaneurol.2022.4804

Evidence-based review of TAC management including oxygen, triptans, verapamil, and neuromodulation for refractory cases

Robbins MS. Diagnosis and Management of Headache: A Review. JAMA. 2021;325(18):1874-1885.[3]

https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2021.1640

Clinical overview of cluster headache (0.1% lifetime prevalence, 3:1 male:female), TACs, tension-type headache, and migraine diagnosis/treatment

Leone M, Bussone G. Pathophysiology of Trigeminal Autonomic Cephalalgias. Lancet Neurol. 2009;8(8):755-64.[4]

https://pubmed.ncbi.nlm.nih.gov/19608101

Detailed pathophysiology of TACs including trigeminal-autonomic reflex and hypothalamic activation

Hoffmann J, May A. Diagnosis, Pathophysiology, and Management of Cluster Headache. Lancet Neurol. 2018;17(1):75-83.[5]

https://pubmed.ncbi.nlm.nih.gov/29174963

Comprehensive review of cluster headache treatment including oxygen (effective within 15-20 min), subcutaneous sumatriptan, and neuromodulation

Indomethacin-Responsive TACs:

Bahra A. Paroxysmal Hemicrania and Hemicrania Continua: Review on Pathophysiology, Clinical Features and Treatment. Cephalalgia. 2023;43(11):3331024231214239.[6]

https://pubmed.ncbi.nlm.nih.gov/37950675

Clinical features and absolute indomethacin responsiveness as diagnostic hallmark for paroxysmal hemicrania and hemicrania continua

Tension-Type Headache:

Ashina S, Mitsikostas DD, Lee MJ, et al. Tension-Type Headache. Nat Rev Dis Primers. 2021;7(1):24.[7]

https://pubmed.ncbi.nlm.nih.gov/33767185

Authoritative primer on TTH epidemiology (most prevalent neurological disorder worldwide), pathophysiology, and evidence-based treatment

Steelquist J, Pham A, Vu K, Eapen BC. Assessment and Management of Tension-Type Headaches. Phys Med Rehabil Clin N Am. 2025;36(4):715-725.[8]

https://pubmed.ncbi.nlm.nih.gov/41167852

2025 review covering acute management (simple analgesics), preventive therapy (tricyclics, SNRIs), and integrative approaches

Bendtsen L, Ashina S, Moore A, Steiner TJ. Muscles and Their Role in Episodic Tension-Type Headache: Implications for Treatment. Eur J Pain. 2016;20(2):166-75.[9]

https://pubmed.ncbi.nlm.nih.gov/26147739

Evidence for peripheral myofascial mechanisms and recommendations for ibuprofen 400 mg and aspirin 1000 mg as first-line acute treatment

Neuromodulation for TACs:

Láinez MJ, Guillamón E. Cluster Headache and Other TACs: Pathophysiology and Neurostimulation Options. Headache. 2017;57(2):327-335.[10]

https://pubmed.ncbi.nlm.nih.gov/28128461
Source: https://www.premierneurohealth.com/